Minako Mori1,2, Asuka Hira1, Kenichi Yoshida3, Hideki Muramatsu4, Yusuke Okuno4, Michiko Ammae5, Kazuo Tamura6, Jun Yasuda7, Tomoo Osumi8, Yasushi Noguchi9, Hiroshi Kawabata10, Akifumi Takaori-Kondo2, Seiji Kojima4, Seishi Ogawa3,11, Hiromasa Yabe12, Miharu Yabe12, Minoru Takata1 (1.Radiation Biology Center, Kyoto University, Kyoto, Japan, 2.Hematology and Oncology, Kyoto University, Kyoto, Japan, 3.Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 4.Pediatrics, Nagoya University, Nagoya, Japan, 5.Sunkaky Medical Corporation IVF Namba Clinic, Osaka, Japan, 6.Medical Genetics Laboratory, Kindai University, Osaka, Japan, 7.Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan, 8.Children's Cancer Center, NCCHD, Tokyo, Japan, 9.Pediatrics, Japanese Red Cross Narita Hospital, Chiba, Japan, 10.Hematology and Immunology, Kanazawa Medical University, Kanazawa, Japan, 11.Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden, 12.Cell Transplantation and Regenerative Medicine, Tokai University, Isehara, Japan)
Session information
Oral Session
Oral Session 3-12C Bone marrow failure: Epidemiology and pathology
Sun. Oct 14, 2018 1:50 PM - 2:50 PM No.12 (Osaka International Convention Center, 10F 1006-7)
Chair: Makoto Hirokawa (Akita University Graduate School of Med., Japan)
Yasuhisa Yokoyama1, Naoshi Obara1, Masahiko Gosho2, Takahiro Suzuki3, Akiyoshi Takami4, Yasushi Miyazaki5, Koichi Akashi6, Shigeru Chiba1 (1.Hematol., Univ. Tsukuba, Ibaraki, Japan, 2.Biostatistics, Univ. Tsukuba, Ibaraki, Japan, 3.Hematol., Kitasato Univ. School Med., Kanagawa, Japan, 4.Hematol., Int. Med., Aichi Med. Univ., Aichi, Japan, 5.Hematol., Atomic Bomb Disease Hibakusha Med., Nagasaki Univ., Nagasaki, Japan, 6.Med. Biosystemic Science, Kyushu Univ., Fukuoka, Japan)
Makoto Hirokawa1, Kenichi Sawada2, Naohito Fujishima2, Masanao Teramura3, Masami Bessho4, Kazuo Dan5, Hisashi Tsurumi6, Shinji Nakao7, Akio Urabe8, Shin Fujisawa9, Yuji Yonemura10, Fumio Kawano11, Kazuo Oshimi12, Koichi Sugimoto12, Akira Matsuda13, Masamitsu Karasawa14, Ayako Arai15, Norio Komatsu12, Hideo Harigae16, Kaoru Tohyama17, Akiko Saito18, Itaru Matsumura19, Mitsuhiro Omine20, Keiya Ozawa21, Mineo Kurokawa22, Shunya Arai22, Kinuko Mitani23 (1.General Intern. Med. Clin. Lab. Med., Akita Univ. Akita, Japan, 2.Hematol., Nephrol. Rheumatol., Akita Uiv., Akita, Japan, 3.Hematol., Tokyo Women's Med. Univ., Tokyo, Japan, 4.Hematol., Saitama Med. Univ., Saitama, Japan, 5.Hematol., Nippon Med. Univ., Tokyo, Japan, 6.First Dept. Intern. Med., Gifu Univ., Gifu, Japan, 7.Cell. Transplant. Biol., Kanazawa Univ., Kanazawa, Japan, 8.Hematol., NTT Med. Ctr., Tokyo, Japan, 9.Hematol., Yokohama City Univ. Med. Ctr., Yokohama, Japan, 10.Transfusion Med. Cell Therapy, Kumamoto Univ., Kumamoto, Japan, 11.Kumamoto Natl. Hosp. Med. Ctr., Kumamoto, Japan, 12.Hematol., Juntendo Univ., Tokyo, Japan, 13.Hematol. Oncol., Int. Med. Ctr., Saitama Med. Univ., Saitama, Japan, 14.Blood Transf. Service, Gunma Univ., Maebashi, Japan, 15.Lab. Mol. Genet. Hematol., Tokyo Med. Dental Univ., Tokyo, Japan, 16.Lab. Med., Kawasaki Med. Sch, Okayama, Japan, 17.Hematol. Immunol., Tohoku Univ., Sendai, Japan, 18.Clin. Res. Ctr., Nagoya Med. Ctr., Nagoya, Japan, 19.Hematol., Kindai Univ., Osaka, Japan, 20.Hematol., Showa Univ. Fujigaoka Hosp., Yokohama, Japan, 21.Hematol., Jichi Med. Sch., Tochigi, Japan, 22.Hematol. Oncol., Univ. Tokyo, Tokyo, Japan, 23.Hematol. Oncol., Dokkyo Med. Univ., Tochigi, Japan)
Yuichi Kodama, Yasuhiro Okamoto, Takanari Abematsu, Shunsuke Nakagawa, Takuro Nishikawa, Takayuki Tanabe, Yuichi Shinkoda, Yoshifumi Kawano (Dept. Ped., Kagoshima Univ., Kagoshima, Japan)
Nao Yoshida1, Atsushi Narita2, Hideki Muramatsu2, Ryoji Kobayashi3, Hiromasa Yabe4, Kazuko Kudo5, Hiroshi Yagasaki6, Kenichiro Watanabe7, Akira Morimoto8, Etsuro Ito9, Shouichi Ohga10, Akira Ohara11, Seiji Kojima2, Yoshiyuki Takahashi2 (1.Pediatric Hematology/Oncology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan, 2.Pediatrics, Nagoya University, Nagoya, Japan, 3.Pediatrics, Sapporo Hokuyu Hospital, Sapporo, Japan, 4.Cell Transplantation and Regenerative Medicine, Tokai University, Isehara, Japan, 5.Pediatrics, Fujita Health University, Toyoake, Japan, 6.Pediatrics, Nihon University, Tokyo, Japan, 7.Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan, 8.Pediatrics, Jichi Medical University, Shimotsuke, Japan, 9.Pediatrics, Hirosaki University, Hirosaki, Japan, 10.Pediatrics, Kyushu University, Fukuoka, Japan, 11.Pediatrics, Toho University, Tokyo, Japan)
Noriharu Nakagawa1,2, Mikoto Tanabe2, Ishikazu Mizuno3, Satoshi Morishige4, Shuji Matsuzawa5, Takahiko Ito6, Masahiko Sumi7, Nobuyuki Takayama8, Ken Ishiyama2, Hirohito Yamazaki9, Shinji Nakao2 (1.Dept. Hematology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan, 2.Dept. Hematology, Kanazawa University Hospital, Kanazawa, Japan, 3.Dept. Hematology, Hyogo Cancer Center, Akashi, Japan, 4.Div. Hematology and Oncology, Kurume University School, Kurume, Japan, 5.Dept. Hematology, NHO Matsumoto Medical Center Matsumoto Hospital, Matsumoto, Japan, 6.Dept. Hematology, JCHO Kani Tono Hospital, Kani, Japan, 7.Dept. Hematology, Nagano Red Cross Hospital, Nagano, Japan, 8.Second Department of Internal Medicine, Kyorin University School, Mitaka, Japan, 9.Div. Transfusion Medicine, Kanazawa University Hospital, Kanazawa, Japan)